Elaine K. Sorg - Feb 28, 2023 Form 4 Insider Report for AbbVie Inc. (ABBV)

Role
SVP, US COMMERCIAL OPERATIONS
Signature
Steven L. Scrogham, attorney-in-fact for Elaine K. Sorg
Stock symbol
ABBV
Transactions as of
Feb 28, 2023
Transactions value $
-$5,387,923
Form type
4
Date filed
3/2/2023, 04:07 PM
Previous filing
Feb 21, 2023
Next filing
Apr 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABBV Common Stock, $0.01 par value Tax liability -$3.06M -19.9K -31.67% $154.28 42.8K Feb 28, 2023 Direct
transaction ABBV Common Stock, $0.01 par value Options Exercise $1.4M +15K +35.03% $93.50 57.8K Mar 1, 2023 Direct
transaction ABBV Common Stock, $0.01 par value Sale -$2.33M -15K -25.94% $155.00 42.8K Mar 1, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABBV Option (Right to Buy) Options Exercise -$1.4M -15K -100% $93.50 0 Mar 1, 2023 Common Stock 15K $93.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

Remarks:

The option exercise and sale transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).